Cargando…
Detection of Aberrant Glycosylation of Serum Haptoglobin for Gastric Cancer Diagnosis Using a Middle-Up-Down Glycoproteome Platform
Gastric cancer is a frequently occurring cancer and is the leading cause of cancer-related deaths. Recent studies have shown that aberrant glycosylation of serum haptoglobin is closely related to gastric cancer and has enormous potential for use in diagnosis. However, there is no platform with high...
Autores principales: | Jeong, Seunghyup, Kim, Unyong, Oh, Myungjin, Nam, Jihyeon, Park, Sehoon, Choi, Yoonjin, Lee, Dongho, Kim, Jaehan, An, Hyunjoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235735/ https://www.ncbi.nlm.nih.gov/pubmed/34207451 http://dx.doi.org/10.3390/jpm11060575 |
Ejemplares similares
-
Direct analysis of aberrant glycosylation on haptoglobin in patients with gastric cancer
por: Kim, Jae-Han, et al.
Publicado: (2016) -
Integrative glycoproteomics reveals protein N-glycosylation aberrations and glycoproteomic network alterations in Alzheimer’s disease
por: Zhang, Qi, et al.
Publicado: (2020) -
Protein N-glycosylation aberrations and glycoproteomic network alterations in osteoarthritis and osteoarthritis with type 2 diabetes
por: Luo, Yi, et al.
Publicado: (2022) -
Targeted glycoproteomic identification of cancer cell glycosylation
por: Powlesland, Alex S, et al.
Publicado: (2009) -
An Integrated Mass Spectrometry-Based Glycomics-Driven Glycoproteomics Analytical Platform to Functionally Characterize Glycosylation Inhibitors
por: Alvarez, Michael Russelle S., et al.
Publicado: (2022)